Page last updated: 2024-11-04

2,2'-azobis(2-amidinopropane)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1969
CHEMBL ID1623736
CHEMBL ID1619966
CHEBI ID94003
SCHEMBL ID246818
MeSH IDM0135276

Synonyms (32)

Synonym
NSC668416 ,
NCI60_023858
13217-66-8
abaph
amph cpd
2,2'-azobis(2-methylpropionamidine)
2,2'-azobis(2-amidinopropane)
{2,2'-azobis[2-amidinopropane]dihydrochloride}
2-[(e)-(2-amino-2-imino-1,1-dimethyl-ethyl)azo]-2-methyl-propanamidine
2,2'-azobis[2-amidinopropane]dihydrochloride
aaph
2-[(1-amino-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidamide
2,2'-azobis(2-amidinopropane)hydrochloride
propanimidamide, 2,2'-azobis(2-methyl-
BRD-K32188552-300-01-6
SCHEMBL246818
CHEMBL1623736
CHEMBL1619966
2,2'-azo-bis-2-aminopropane
CCTFAOUOYLVUFG-BUHFOSPRSA-N
2,2'-azobis-2-methylpropanimidamide
CHEBI:94003
azo-bisisobutyroamidine
CCTFAOUOYLVUFG-UHFFFAOYSA-N
2-(1-amino-1-imino-2-methylpropan-2-yl)azo-2-methylpropanimidamide
Q27165754
2-[(2-amino-2-imino-1,1-dimethylethyl)diazenyl]-2-methylpropanimidamide
AU-004/43508304
2,2/'-azobis(2-amidinopropane)
DTXSID001335783
2,2'-diazenediylbis(2-methylpropanimidamide)
2,2'-azobis(2-methylpropioamidine)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" On the other hand, this method allows to study mechanisms of the toxic action of xenobiotics on cells (erythrocytes) and organelles (mitochondria), strongly implicated in the free radical generation, and to examine the role of the extracellular liquid (plasma)."( Toxicity of pyrimidine derivatives under oxidative stress conditions: chemiluminescence-based assays in systems containing erythrocytes, mitochondria or blood plasma.
Sajewicz, W,
)
0.13
" This data provides useful information to help design safe antioxidant products that act without altering critical cell functions."( Comparative antioxidant and cytotoxic effect of procyanidin fractions from grape and pine.
Mitjans, M; Torres, JL; TouriƱo, S; Ugartondo, V; Vinardell, MP, 2007
)
0.34
"N-acetyl-tryptophan and L-methionine effectively reduce the oxidation of susceptible tryptophan and methionine residues in antibodies and are safe for use in parenteral biotherapeutic formulations."( Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine.
Dion, MZ; Leiske, D; Salisbury, CM; Sharma, VK; Zuch de Zafra, CL, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" Since ROS also bind to nitric oxide (NO) and reduce the bioavailability of NO, heparin may indirectly increase the bioavailability of NO and thus act as a vasodilator."( Heparin inhibits reactive oxygen species generation by polymorphonuclear and mononuclear leucocytes.
Aljada, A; Bakri, F; Dandona, P; Hamouda, W; Kumbkarni, Y; Qutob, T, 1999
)
0.3
" cell-mediated) types of action in protecting LDL against oxidation, strengthening the need for improving the knowledge of its bioavailability in humans."( Grape and grape seed extract capacities at protecting LDL against oxidation generated by Cu2+, AAPH or SIN-1 and at decreasing superoxide THP-1 cell production. A comparison to other extracts or compounds.
Carbonneau, MA; Descomps, B; Leger, CL; Shafiee, M; Urban, N, 2003
)
0.32
" The bioavailability and efficacy of antioxidants in human corneal limbal epithelial (HCLE) cells were measured to determine whether antioxidants might be beneficial constituents of lubricant eye drops."( Bioavailability of antioxidants applied to stratified human corneal epithelial cells.
Koetje, LR; Mitchell, AK; Schotanus, MP; Stoddard, AR; Ubels, JL, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monoazo compoundCompounds containing single -N=N- group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (747)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (2.14)18.7374
1990's262 (35.07)18.2507
2000's282 (37.75)29.6817
2010's154 (20.62)24.3611
2020's33 (4.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.38 (24.57)
Research Supply Index6.66 (2.92)
Research Growth Index5.86 (4.65)
Search Engine Demand Index52.69 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials9 (1.17%)5.53%
Reviews4 (0.52%)6.00%
Case Studies2 (0.26%)4.05%
Observational0 (0.00%)0.25%
Other754 (98.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]